{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:54:54Z","timestamp":1791298494576,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Patient Education and Counseling"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.pec.2026.109823","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:08:24Z","timestamp":1787008104000},"page":"109823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Why do some patients adhere worse? The role of frailty and depression in Parkinson disease"],"prefix":"10.1016","volume":"152","author":[{"given":"Aleksandra","family":"Pytel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edyta","family":"Kocierz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaudia","family":"B\u0142achnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szyma\u0144ska-Chabowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Dusi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9232-4525","authenticated-orcid":false,"given":"Mariusz","family":"Chabowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pec.2026.109823_bib1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ncl.2016.06.012","article-title":"Epidemiology of Parkinson disease","volume":"34","author":"Lee","year":"2016","journal-title":"Neurol Clin"},{"key":"10.1016\/j.pec.2026.109823_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.776847","article-title":"Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019","volume":"9","author":"Ou","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/j.pec.2026.109823_bib3","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pec.2026.109823_bib4","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Abbafati","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.pec.2026.109823_bib5","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.pec.2026.109823_bib6","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.23823","article-title":"MDS Task Force on Mild Cognitive Impairment in Parkinson\u2019s disease: critical review of PD-MCI","volume":"26","author":"Litvan","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.pec.2026.109823_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2010.08.009","article-title":"The frailty syndrome: definition and natural history","volume":"27","author":"Xue","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.pec.2026.109823_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018195","article-title":"Prevalence of frailty and prefrailty among community-dwelling older adults in low-income and middle-income countries: a systematic review and meta-analysis","volume":"8","author":"Siriwardhana","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.pec.2026.109823_bib9","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.pec.2026.109823_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101840","article-title":"Neurobiology of depression in Parkinson\u2019s disease: insights into epidemiology, molecular mechanisms and treatment strategies","volume":"85","author":"Ahmad","year":"2023","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.pec.2026.109823_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/jnp.13.2.187","article-title":"Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson\u2019s disease","volume":"13","author":"Slaughter","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.pec.2026.109823_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2019.04.002","article-title":"Depression in neurodegenerative diseases: common mechanisms and current treatment options","volume":"102","author":"Galts","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pec.2026.109823_bib13","doi-asserted-by":"crossref","unstructured":"Meichenbaum D., Turk D.C. Facilitating treatment adherence: a practitioner\u2019s guidebook. New York: Plenum Press; 1987.","DOI":"10.1007\/978-1-4684-5359-1"},{"key":"10.1016\/j.pec.2026.109823_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.parkreldis.2014.10.021","article-title":"Relationships between antiparkinson medication nonadherence, regimen modifications, and healthcare utilization and expenditures","volume":"21","author":"Wei","year":"2015","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.pec.2026.109823_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40263-014-0220-0","article-title":"Medication adherence in patients with Parkinson\u2019s disease","volume":"29","author":"Malek","year":"2015","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pec.2026.109823_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/mds.21831","article-title":"Medication adherence and associated outcomes in Medicare health maintenance organization-enrolled older adults with Parkinson\u2019s disease","volume":"23","author":"Kulkarni","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.pec.2026.109823_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s40258-013-0033-1","article-title":"Compliance with pharmacotherapy and direct healthcare costs in patients with Parkinson\u2019s disease: a retrospective claims database analysis","volume":"11","author":"Richy","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.pec.2026.109823_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jval.2013.12.003","article-title":"Antiparkinson drug adherence and its association with health care utilization and economic outcomes in a Medicare Part D population","volume":"17","author":"Wei","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.pec.2026.109823_bib19","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/mds.20602","article-title":"Suboptimal medication adherence in Parkinson\u2019s disease","volume":"20","author":"Grosset","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.pec.2026.109823_bib20","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1186\/s12889-024-18431-y","article-title":"Medication adherence and costs of medical care among patients with Parkinson\u2019s disease: an observational study using electronic medical records","volume":"24","author":"Yi","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.pec.2026.109823_bib21","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/mds.22999","article-title":"Prevalence and cost of medication nonadherence in Parkinson\u2019s disease: evidence from administrative claims data","volume":"25","author":"Davis","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.pec.2026.109823_bib22","doi-asserted-by":"crossref","first-page":"15226","DOI":"10.3390\/ijerph192215226","article-title":"The effect of frailty syndrome on the quality of life of individuals with Parkinson\u2019s disease: a pilot observational and multicenter study on the Polish population","volume":"19","author":"Pytel","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.pec.2026.109823_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2026.1720699","article-title":"The rising tide of frailty in Parkinson\u2019s disease: a bibliometric study of global research landscape and emerging trends","volume":"17","author":"Jin","year":"2026","journal-title":"Front Neurol"},{"key":"10.1016\/j.pec.2026.109823_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/jcm15010063","article-title":"Parkinson\u2019s disease and frailty: a two-way link across aging","volume":"15","author":"Hern\u00e1ndez-Triana","year":"2026","journal-title":"J Clin Med"},{"key":"10.1016\/j.pec.2026.109823_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2022.05.004","article-title":"Frailty in Parkinson's disease and its association with early dementia: a longitudinal study","volume":"99","author":"Borda","year":"2022","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.pec.2026.109823_bib26","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.2147\/PPA.S529538","article-title":"Medication adherence in Parkinson\u2019s disease: longitudinal changes and the influence of depressive symptoms","volume":"19","author":"Heimrich","year":"2025","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.pec.2026.109823_bib27","series-title":"Narz\u0119dzia pomiaru w promocji i psychologii zdrowia","author":"Juczy\u0144ski","year":"2009"},{"key":"10.1016\/j.pec.2026.109823_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1353-8020(01)00009-8","article-title":"Reliability of measurements of patient health status: a comparison of physician, patient, and caregiver ratings","volume":"8","author":"McRae","year":"2002","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.pec.2026.109823_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson\u2019s Disease Questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score","volume":"26","author":"Jenkinson","year":"1997","journal-title":"Age Ageing"},{"key":"10.1016\/j.pec.2026.109823_bib30","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2004.05.007","article-title":"Validity and reliability of the PDQ-39 and the PDQ-8 in English-speaking Parkinson's disease patients in Singapore","volume":"10","author":"Tan","year":"2004","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.pec.2026.109823_bib31","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4306\/pi.2017.14.1.30","article-title":"Reliability and validity of the Beck Depression Inventory-II among Korean adolescents","volume":"14","author":"Lee","year":"2017","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.pec.2026.109823_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.5603\/PJNNS.a2020.0049","article-title":"Validation of the Polish version of the Movement Disorder Society-Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS)","volume":"54","author":"Siuda","year":"2020","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.pec.2026.109823_bib33","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/mds.10248","article-title":"Systematic evaluation of rating scales for impairment and disability in Parkinson\u2019s disease","volume":"17","author":"Ramaker","year":"2002","journal-title":"Mov Disord"},{"key":"10.1016\/j.pec.2026.109823_bib34","first-page":"27","article-title":"Validity and reliability of the Polish version of the Tilburg Frailty Indicator (TFI)","volume":"5","author":"Uchmanowicz","year":"2016","journal-title":"J Frailty Aging"},{"key":"10.1016\/j.pec.2026.109823_bib35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1524-4733.2008.00400.x","article-title":"Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease","volume":"12","author":"Kripalani","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.pec.2026.109823_bib36","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6741280","article-title":"Adherence to medication among Parkinson\u2019s disease patients using the Adherence to Refills and Medications Scale","volume":"2022","author":"Radojevi\u0107","year":"2022","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.pec.2026.109823_bib37","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3389\/fneur.2019.00799","article-title":"Adherence to pharmacotherapy in patients with Parkinson\u2019s disease taking three and more daily doses of medication","volume":"10","author":"Straka","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.pec.2026.109823_bib38","doi-asserted-by":"crossref","first-page":"22","DOI":"10.5770\/cgj.24.437","article-title":"ReSPOnD Trial Group. The association between frailty and Parkinson\u2019s disease in the ReSPOnD Trial","volume":"24","author":"Smith","year":"2021","journal-title":"Can Geriatr J"},{"key":"10.1016\/j.pec.2026.109823_bib39","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1111\/jgs.18343","article-title":"The association between frailty and the risk of medication-related problems among community-dwelling older adults in Europe","volume":"71","author":"Ye","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pec.2026.109823_bib40","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1016\/j.pec.2020.05.013","article-title":"The association between frailty and medication adherence among community-dwelling older adults with chronic diseases: medication beliefs acting as mediators","volume":"103","author":"Qiao","year":"2020","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.pec.2026.109823_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1283416","article-title":"Frailty and medication adherence among older adult patients with hypertension: a moderated mediation model","volume":"11","author":"Wang","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.pec.2026.109823_bib42","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2147\/CIA.S113994","article-title":"The influence of frailty syndrome on medication adherence among elderly patients with hypertension","volume":"11","author":"Jankowska-Pola\u0144ska","year":"2016","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.pec.2026.109823_bib43","doi-asserted-by":"crossref","DOI":"10.1590\/s1980-220x2018048903590","article-title":"Partezani RA. Treatment adherence and frailty syndrome in hypertensive older adults","volume":"54","author":"Silva","year":"2020","journal-title":"Rev Esc Enferm USP"},{"key":"10.1016\/j.pec.2026.109823_bib44","first-page":"S85","article-title":"Multimorbidity and frailty: tackling complexity in Parkinson\u2019s disease","volume":"10","author":"Tenison","year":"2020","journal-title":"J Park Dis"},{"key":"10.1016\/j.pec.2026.109823_bib45","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/jgs.14032","article-title":"Multifaceted prospective memory intervention to improve medication adherence","volume":"64","author":"Insel","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pec.2026.109823_bib46","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s10072-013-1438-1","article-title":"Adherence to anti-Parkinson drug therapy in the \u201cREASON\u201d sample of Italian patients with Parkinson\u2019s disease: the linguistic validation of the Italian version of the \u201cMorisky Medical Adherence Scale-8 items","volume":"34","author":"Fabbrini","year":"2013","journal-title":"Neurol Sci"},{"key":"10.1016\/j.pec.2026.109823_bib47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1017\/S1463423615000365","article-title":"Depression, patient characteristics, and attachment style: correlates and mediators of medication treatment adherence in a racially diverse primary care sample","volume":"17","author":"Hooper","year":"2016","journal-title":"Prim Health Care Res Dev"},{"key":"10.1016\/j.pec.2026.109823_bib48","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.2147\/PPA.S426844","article-title":"A predictive model for identifying low medication adherence among patients with cirrhosis","volume":"17","author":"Wang","year":"2023","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.pec.2026.109823_bib49","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1186\/s12913-019-4399-0","article-title":"Variation in the 11-year trajectories of medical care seeking behaviors in diabetes patients under a single payer system: persisting gaps to be filled","volume":"19","author":"Tsai","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.pec.2026.109823_bib50","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4278\/ajhp.090123-QUAN-26","article-title":"Medication adherence among rural, low-income hypertensive adults: a randomized trial of a multimedia community-based intervention","volume":"25","author":"Martin","year":"2011","journal-title":"Am J Health Promot"},{"key":"10.1016\/j.pec.2026.109823_bib51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/apc.2007.0069","article-title":"The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV","volume":"22","author":"Vranceanu","year":"2008","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.pec.2026.109823_bib52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yebeh.2015.06.042","article-title":"Depression and anxiety are associated with reduced antiepileptic drug adherence in Chinese patients","volume":"50","author":"Guo","year":"2015","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.pec.2026.109823_bib53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1037\/hea0000136","article-title":"Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis","volume":"34","author":"Hilliard","year":"2015","journal-title":"Health Psychol"},{"key":"10.1016\/j.pec.2026.109823_bib54","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/1090198107309459","article-title":"Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans","volume":"36","author":"Schoenthaler","year":"2009","journal-title":"Health Educ Behav"},{"key":"10.1016\/j.pec.2026.109823_bib55","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/13548506.2021.1894343","article-title":"Moderating the relationship between diabetes distress and mastery: the role of depression and empowerment","volume":"27","author":"McGuigan","year":"2022","journal-title":"Psychol Health Med"},{"key":"10.1016\/j.pec.2026.109823_bib56","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.2337\/dc07-0158","article-title":"Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity","volume":"30","author":"Gonzalez","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pec.2026.109823_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1370\/afm.1344","article-title":"Integrated management of type 2 diabetes mellitus and depression treatment to improve medication adherence: a randomized controlled trial","volume":"10","author":"Bogner","year":"2012","journal-title":"Ann Fam Med"},{"key":"10.1016\/j.pec.2026.109823_bib58","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s11606-014-2845-6","article-title":"Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE)","volume":"29","author":"Bauer","year":"2014","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.pec.2026.109823_bib59","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1370\/afm.423","article-title":"Effects of enhanced depression treatment on diabetes self-care","volume":"4","author":"Lin","year":"2006","journal-title":"Ann Fam Med"}],"container-title":["Patient Education and Counseling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399126003563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738399126003563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:38:35Z","timestamp":1791297515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738399126003563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":59,"alternative-id":["S0738399126003563"],"URL":"https:\/\/doi.org\/10.1016\/j.pec.2026.109823","relation":{},"ISSN":["0738-3991"],"issn-type":[{"value":"0738-3991","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why do some patients adhere worse? The role of frailty and depression in Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"Patient Education and Counseling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pec.2026.109823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109823"}}